Human Health and Potential (HHP)
Catching a COVID co-conspirator
30 May 2023Researchers identify an unexpected synergy between bacterial and viral molecules that causes severe inflammation in some patients with COVID-19.
Vanda (Papilionanthe) Miss Joaquim’s genome in full bloom
18 May 2023Scientists discover genes encoding colours, scents and bioactive compounds in the genome of Papilionanthe Miss Joaquim, Singapore’s National Flower.
A deeper mind-machine connection
16 May 2023A newly developed artificial neuron detects subtle chemical signals produced by brain cells to power advanced brain-machine interfaces.
Extinguishing the flames of inflammation
12 May 2023Researchers unravel a complex inflammatory pathway involved in severe COVID-19 infection and identify a therapeutic mechanism to reverse it.
Stem cell megacities come to life
10 May 2023A*STAR researchers develop a high-efficiency technique for scaling up stem cell manufacturing for clinical and research applications.
Fluffy scaffolds boost healing
2 May 2023Electrospun scaffolds mirror the structural architecture of the skin’s dermis, creating a foundation to promote healing in chronic wounds.
Brain immunity through the ages
28 Apr 2023A new analytical platform reveals signature changes in immune cells of the brain during aging and neurodegenerative conditions such as Alzheimer’s disease.
Mixing boosters strengthen vaccine protection
24 Apr 2023An analysis of cellular immune responses reveals that mixing COVID-19 vaccines and boosters may offer enhanced protection for at-risk populations.
How cancer seizes the immortality gene
21 Apr 2023Researchers have discovered a molecular pathway in colorectal cancer cells that leads to uncontrolled division, creating an avenue for more targeted therapies.
To catch a skipped beat
14 Apr 2023By analysing heart cells, a new machine learning algorithm could help predict arrhythmia risk before symptoms appear.
mRNA boosters: our best bet against Omicron?
12 Apr 2023Booster shots with COVID-19 mRNA outperformed inactivated virus by eliciting stronger antibody responses to the Omicron variant.
One hundred mini livers on a chip
5 Apr 2023A new microfluidic liver-on-a-chip platform offers drug developers a stable, scalable and sensitive testing ground for much-needed treatments in fatty liver disease.